Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Teicoplanin nephrotoxicity: first case report.

R F Frye1, M L Job, R H Dretler

  • 1Dekalb Medical Center, Decatur, Georgia.

Pharmacotherapy
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis.

Alimentary pharmacology & therapeutics·2017
Same author

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Effect of valerian, valerian/hops extracts, and valerenic acid on glucuronidation in vitro.

Xenobiotica; the fate of foreign compounds in biological systems·2007
Same author

Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.

British journal of clinical pharmacology·2006
Same author

Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients.

The International journal of artificial organs·2005
Same author

The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.

British journal of clinical pharmacology·2004
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

This case report details a patient with diabetes mellitus who developed acute interstitial nephritis and renal failure after treatment with teicoplanin for osteomyelitis. Long-term teicoplanin therapy may necessitate careful renal function monitoring.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Osteomyelitis of the great toe in a patient with type I diabetes mellitus.
  • Treatment with an investigational protocol involving teicoplanin (1200 mg/day).

Observation:

  • Development of significantly elevated serum creatinine and blood urea nitrogen after 40 days of teicoplanin.
  • Proteinuria and marked eosinophilia observed in blood analysis.
  • Diagnosis of probable drug-induced acute interstitial nephritis.

Findings:

  • Standard treatment with furosemide and hemodialysis did not improve renal function.
  • Patient required referral for long-term dialysis.
  • Suggests a potential link between teicoplanin and drug-induced renal failure.

Related Experiment Videos

Implications:

  • Highlights the risk of teicoplanin-induced nephrotoxicity, particularly in patients with pre-existing conditions.
  • Recommends periodic renal function monitoring for patients undergoing long-term teicoplanin therapy.
  • Underscores the importance of considering drug-induced causes in acute kidney injury cases.